Corey McCann - Feb 16, 2022 Form 4 Insider Report for Pear Therapeutics, Inc. (PEARQ)

Role
President and CEO, Director
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Stock symbol
PEARQ
Transactions as of
Feb 16, 2022
Transactions value $
$0
Form type
4
Date filed
2/18/2022, 03:40 PM
Previous filing
Dec 7, 2021
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PEARQ Class A Common Stock 8.16M Feb 16, 2022 Direct F1
holding PEARQ Class A Common Stock 1.69M Feb 16, 2022 by The Corey M. McCann Irrevocable Trust of 2021 F2, F3
holding PEARQ Class A Common Stock 987K Feb 16, 2022 by The McCann Family Trust F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Stock Option (Right to Buy) Award $0 +210K $0.00 210K Feb 16, 2022 Common Stock 210K $4.06 Direct F5
transaction PEARQ Restricted Stock Units Award $0 +267K $0.00 267K Feb 16, 2022 Common Stock 267K Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Updated to correct error in prior Form 4 filing.
F2 The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, with respect to these shares, except to the extent of his pecuniary interest therein.
F3 Shares held in The Corey M. McCann Irrevocable Trust of 2021. The trustee of The Corey M. McCann Irrevocable Trust of 2021 is Mia E. Moll.
F4 Shares held in The McCann Family Trust. The trustee of The McCann Family Trust is Concord Trust Company.
F5 25% of the shares underlying the option shall vest on January 14, 2023 and an additional 2.0833 and 1/3% of the shares shall vest on the last day of each calendar month thereafter.
F6 Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
F7 The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025.